You are here: Industry Insights > Antibiotics

News List

Most U.K. Patients With UTI Receive Antibiotics on Same Day drugs
August 21, 2019
More than 85 percent of patients with urinary tract infection (UTI) receive antibiotics the same day and more than half are treated with trimethoprim, according to a study published online in EClinicalMedicine.
Many Americans Take Antibiotics Without a Prescription drugs
July 23, 2019
No one would argue that antibiotics are an amazing 20th-century innovation, promising a quick cure for bacterial illnesses that might otherwise cause serious harm or death.
Many Pneumonia Patients Get Too Many Antibiotics drugs
July 15, 2019
Two-thirds of hospitalized pneumonia patients may be prescribed antibiotics for too long, increasing their risk for potentially harmful side effects, researchers say.
Hospitalized Pneumonia Patients Often Get Excess Antibiotics drugs
July 12, 2019
Patients hospitalized with pneumonia often receive excess antibiotic therapy, according to a study published online in the Annals of Internal Medicine.
Appili Signs Grant Contract with DOD to Develop “Superbugs” Antibiotics americanpharmaceuticalreview
July 03, 2019
Appili Therapeutics announced the United States Department of Defense, (DOD) Congressionally Directed Medical Research Programs, Peer Reviewed Medical Research Program (PRMRP) has completed the contract awarding the Company a $3.0 million USD grant.
Civica Rx and Xellia Join Forces to Reduce Chronic Drug Shortages contractpharma
May 17, 2019
Xellia becomes Civica’s first supplier partner and will produce essential antibiotics in short supply in U.S. hospitals.
Achaogen seeks near-term sale through bankruptcy process fiercebiotech
April 17, 2019
Achaogen is looking to sell its assets and close out its affairs through the bankruptcy process. News of the Chapter 11 filing comes 10 months after Achaogen won FDA approval for its antibiotic Zemdri.
Evotec and GARDP partner to identify new antibiotics pharmaceutical-technology
March 20, 2019
German drug discovery firm Evotec has partnered with Swiss non-profit The Global Antibiotic Research and Development Partnership (GARDP) to discover new antibiotics to address the growing threat of antimicrobial resistance (AMR).
Expansion of the global antibiotics market size europeanpharmaceuticalreview
March 01, 2019
The global antibiotics market is set to increase at a CAGR of 4 percent to $62.06 billion, due to the rising prevalence of infectious diseases…
Sepsis Common in Terminal Hospitalizations, Discharges drugs
February 18, 2019
More than half of hospitalized patients who die or are terminally discharged have sepsis, according to a study published online Feb. 15 in JAMA Network Open....

Previous page 1 2 3 4 5 6 7 8 Next page